Three compounding pharmacies issued voluntary nationwide recalls of injectable glutathione products between August 5 and September 9, 2026, after identifying elevated bacterial endotoxin levels in their vials. The most recent recall, from Centric Compounding on September 9, named the likely cause: a Glutathione API that itself contained elevated endotoxins, not a handling error inside the pharmacy.
The Three Recalls, Newest First
Centric Compounding (September 9, 2026). Six lots of Glutathione 200 mg/mL, plus Myers' Cocktail and Tri-Immune Boost injectable vials, were recalled. Centric stated the products "were compounded with a Glutathione API containing elevated endotoxin levels". The clearest acknowledgment in the three actions that the contamination originated in the raw ingredient. (FDA recall announcement)
Optimal Balance Pharmacy (August 19, 2026). One lot of Compounded Glutathione 200 mg/mL Multi-Dose Vials was recalled after pharmacy testing found elevated endotoxin levels. The recall reached consumers in Arizona, Colorado, Florida, Illinois, Louisiana, Michigan, New York, Nevada, Oklahoma, Pennsylvania, Texas, Utah, Vermont, and Washington. (FDA recall announcement)
Victory Medical Center Pharmacy (August 5, 2026). The earliest of the three, also involving Compounded Glutathione 200 mg/mL Multi-Dose Vials. The FDA recall announcement cites risks including fevers, hypotension, inflammatory reactions, anaphylactic shock, and death. (FDA recall announcement)
Why Endotoxins Are the Recurring Problem
Endotoxins are lipopolysaccharides shed from the cell walls of gram-negative bacteria. They survive sterilization that kills the bacteria themselves, so a contaminated starting material can pass standard sterility testing while still carrying enough endotoxins to cause fever, chills, rigors, and, at higher levels, cardiovascular collapse when injected.
The FDA has documented the upstream cause in at least one related investigation: some compounding pharmacies source their glutathione active pharmaceutical ingredient from dietary supplement grade suppliers rather than pharmaceutical grade suppliers. Supplement grade raw materials are manufactured under looser controls and are not validated for the endotoxin limits required for injectable drug use. When the API arrives contaminated, a pharmacy's own batch handling cannot fully correct it.
The Centric recall language points directly to this pattern. The FDA has also separately reminded compounders not to use dietary supplement grade glutathione for injectables, citing patient adverse events (fevers, chills, pain, dizziness, and sepsis-like symptoms) reported following administration of products made with ingredient sourced from Medisca Inc. (FDA reminder)
What This Does Not Mean
These recalls involve compounding pharmacies. Not the telehealth clinics that write prescriptions for glutathione therapy. A clinic sourcing from a pharmacy that uses pharmaceutical grade API and performs documented batch release testing is operating outside the pattern these recalls describe. The actions do not implicate any specific telehealth provider.
What the pattern does signal: the relevant question for a patient is not just "do you use a licensed pharmacy?" but "does your pharmacy source pharmaceutical grade, injection-grade API, and does it release a certificate of analysis on every lot before dispensing?"
What to Ask Before Starting Injectable Glutathione
- API grade. Pharmaceutical grade versus dietary supplement grade are different specifications with different endotoxin limits. Ask which your pharmacy uses.
- Batch COA. Does the pharmacy issue a certificate of analysis for each lot? Will your clinic share it with you?
- 503A versus 503B. A 503B outsourcing facility operates under current Good Manufacturing Practice standards with regular FDA inspection. A higher standard than a traditional 503A patient-specific pharmacy. Not all clinics disclose which type they use.
Clinics in our ranking that publicly address their compounding sources: HealthRX states it uses FDA-registered facilities; Luvo Health specifies both 503A and 503B pharmacies. Our bmiMD review notes that the clinic states batch quality checks are performed by licensed pharmacists, though the certificate is described as available on request rather than published.
For the broader compounding enforcement picture in 2026, see our earlier piece on FDA warning letters to peptide compounders.
Every clinic we review that offers glutathione, with the price we read on its own pages, is on our glutathione page.
Sources: FDA recall (Centric Compounding, Sep 9 2026; FDA recall) Optimal Balance Pharmacy, Aug 19 2026; FDA recall. Victory Medical Center Pharmacy, Aug 5 2026; FDA reminder on dietary supplement grade glutathione.
